Understanding Multidrug-Resistant Pathogens (MDR) and Antimicrobial Stewardship in CAP

Opinion
Video

An expert in infectious diseases comments on multidrug-resistant pathogens such as pneumococcus in CAP, and shares thoughts on balancing antimicrobial stewardship with the pharmacoeconomics of antimicrobial therapies in CAP.

Related Videos
Related Content
CDC: 2022-2023 Influenza Season 'High Severity'

CDC: 2022-2023 Influenza Season 'High Severity'

November 29th 2023
Article
Tailoring Therapies in Community Acquired Pneumonia in the Inpatient Setting

Tailoring Therapies in Community Acquired Pneumonia in the Inpatient Setting

November 6th 2023
Podcast
Quadrivalent Influenza Vaccines Provide Higher Immunogenicity Against B Lineage vs Trivalent

Quadrivalent Influenza Vaccines Provide Higher Immunogenicity Against B Lineage vs Trivalent

November 26th 2023
Article
Vaccine Race: The Pfizer Vaccine with William Schaffner, MD

Vaccine Race: The Pfizer Vaccine with William Schaffner, MD

November 16th 2020
Podcast
Testing for Viral Respiratory Illnesses: Best Practices, Types of Tests, Advantages and Drawbacks, and Patient/Provider Education

Testing for Viral Respiratory Illnesses: Best Practices, Types of Tests, Advantages and Drawbacks, and Patient/Provider Education

November 2nd 2023
Article
Examining RSV Vaccines for Seniors

Examining RSV Vaccines for Seniors

November 2nd 2023
Article
© 2023 MJH Life Sciences

All rights reserved.